Roger Connor, president of GSK Vaccines
Sanofi, GSK prep regulatory filings for Covid-19 vaccine after posting PhIII, booster data — but who will use it?
Armed with the final cut of Phase III results on their Covid-19 vaccine both as a primary series and a booster, Sanofi and GlaxoSmithKline are …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
